NVOS - Novo Integrated Sciences, Inc. Stock Price, Fair Value and News

$0.030.00 (0.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NVOS Price Action

Last 7 days

-25%

Last 30 days

-50%

Last 90 days

-90.3%

Trailing 12 Months

-97.3%

NVOS RSI Chart

NVOS Valuation

Market Cap

571.6K

Price/Earnings (Trailing)

-0.04

Price/Sales (Trailing)

0.04

EV/EBITDA

0.02

Price/Free Cashflow

-0.11

NVOS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NVOS Fundamentals

NVOS Revenue

Revenue (TTM)

13.3M

Rev. Growth (Yr)

-6.74%

Rev. Growth (Qtr)

-2.26%

NVOS Earnings

Earnings (TTM)

-16.1M

Earnings Growth (Yr)

259.78%

Earnings Growth (Qtr)

136.6%

NVOS Profitability

Operating Margin

43.20%

EBT Margin

-121.32%

Return on Equity

-110.3%

Return on Assets

-50.15%

Free Cashflow Yield

-887.78%

NVOS Investor Care

Shares Dilution (1Y)

20.91%

Diluted EPS (TTM)

-0.88

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	13.7M	13.5M	13.3M	0
2023	12.2M	12.4M	12.6M	13.0M
2022	8.9M	20.3M	11.7M	11.9M
2021	7.1M	8.5M	7.1M	8.1M
2020	9.9M	8.4M	7.9M	7.5M
2019	9.0M	9.2M	9.4M	9.7M
2018	8.7M	8.9M	8.9M	9.0M
2017	7.6M	7.8M	8.0M	8.4M
2016	0	0	7.2M	7.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates corporate-owned clinics. The company is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.

CEO	Mr. Robert Mattacchione
WEBSITE	novointegrated.com
SECTOR	Healthcare
INDUSTRY	Medical Care Facilities
EMPLOYEES	115

Novo Integrated Sciences, Inc. Frequently Asked Questions

What is the ticker symbol for Novo Integrated Sciences, Inc.? What does NVOS stand for in stocks?

NVOS is the stock ticker symbol of Novo Integrated Sciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Novo Integrated Sciences, Inc. (NVOS)?

As of Fri Dec 20 2024, market cap of Novo Integrated Sciences, Inc. is 571.64 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVOS stock?

You can check NVOS's fair value in chart for subscribers.

Is Novo Integrated Sciences, Inc. a good stock to buy?

The fair value guage provides a quick view whether NVOS is over valued or under valued. Whether Novo Integrated Sciences, Inc. is cheap or expensive depends on the assumptions which impact Novo Integrated Sciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVOS.

What is Novo Integrated Sciences, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, NVOS's PE ratio (Price to Earnings) is -0.04 and Price to Sales (PS) ratio is 0.04. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVOS PE ratio will change depending on the future growth rate expectations of investors.